Tolerability and Efficacy of Deucravacitinib in the Treatment of Refractory Psoriasis. Planet (Barisal) [Internet]. 2026 May 26 [cited 2026 Jun. 4];9(03):213-8. Available from: https://bdjournals.org/planet/article/view/1195